MAIN CONTENT
Talks remain uncertain
Bloomberg cited people familiar with discussions who said BASF was collecting stakeholder input before a proposal that could arrive within days. Reuters reported the account, but it is important to distinguish a potential offer from a signed agreement or completed acquisition. No new purchase price, timetable or definitive terms have been publicly confirmed.
Evonik shares traded at €22.04 at 1521 GMT, still below the previously reported €24-per-share approach. That gap underlines uncertainty over acceptance, financing and regulatory scrutiny. The 4% rise in Evonik and 2% fall in BASF also suggest that investors are weighing potential benefits against the costs and risks of a larger deal.
Employment guarantees shape the debate
According to Bloomberg, BASF wrote to the North Rhine-Westphalia government, German lawmakers and the RAG Foundation, promising to preserve and broaden existing commitments to employees and industrial sites. For communities built around chemical production, the issue is not merely corporate ownership; it concerns skilled work, suppliers and long-term capital investment.
The practical strength of those assurances depends on details that have not been published: which facilities are covered, whether staffing commitments have deadlines and how promised investment would be monitored. A merger may yield efficiencies, but any savings plan that relies on job reductions would face political and social scrutiny.














